![Alexander Schuth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Schuth
Founder at
DENALI THERAPEUTICS INC.
Net worth: 21 M $ as of 2026-06-29
Profile
Dr. Alexander O. Schuth is a Chief Operating Officer & Secretary at Denali Therapeutics, Inc. He is on the Board of Directors at Molecular Health AG and Molecular Health GmbH. Dr. Schuth was previously employed as a Director-Technology & Diagnostics Partnering by Genentech, Inc. and an Investment Banking Associate by Merrill Lynch International. He received his MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from Charité - Universitätsmedizin Berlin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 806,577 ( 0.51% ) | 21 M $ | 2026-06-29 |
Alexander Schuth active positions
| Companies | Position | Start |
|---|---|---|
| DENALI THERAPEUTICS INC. | Founder | 2013-10-13 |
Molecular Health GmbH
 Molecular Health GmbH Packaged SoftwareTechnology Services Provides data-driven software technology solutions for transforming biomedical data into actionable insights | Director/Board Member | - |
Former positions of Alexander Schuth
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2015-02-28 |
Merrill Lynch International
 Merrill Lynch International Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 2003-04-30 |
Posbelduf Biotech AG
 Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Provides clinico-molecular informatic solutions | Founder | - |
Training of Alexander Schuth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Merrill Lynch International
Merrill Lynch International Investment Banks/BrokersFinance Provides brokerage services | Finance |
Charité - Universitätsmedizin Berlin
 Charité - Universitätsmedizin Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Posbelduf Biotech AG
Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Provides clinico-molecular informatic solutions | Health Technology |
Molecular Health GmbH
Molecular Health GmbH Packaged SoftwareTechnology Services Provides data-driven software technology solutions for transforming biomedical data into actionable insights | Technology Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Alexander Schuth
